Form 4: Cardlytics CFO Alexis DeSieno Reports Stock Transactions
SEC Form 4 Filing
Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On January 1, 2025, Alexis DeSieno, CFO of Cardlytics, Inc., had 14,349 restricted stock units (RSUs) vest, which converted into common stock.
- Following the vesting, DeSieno sold 8,854 shares of common stock on January 3, 2025, at a weighted average price of $3.667 per share to cover tax obligations.
- The sales occurred in multiple transactions with prices ranging from $3.555 to $3.78.
- After these transactions, DeSieno directly owns 121,976 shares of Cardlytics common stock and 71,748 restricted stock units.
- The RSUs vest in eight equal installments from July 1, 2024, to April 1, 2026, contingent upon continued employment.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to executive compensation and tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's sentiment and actions regarding the company's stock.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing the volume and frequency of insider sales to those of peers like LiveRamp or The Trade Desk can provide insights into the relative valuation and management confidence in Cardlytics.
- For example, if executives at LiveRamp are consistently buying shares while Cardlytics executives are selling, it could indicate differing outlooks on the companies' future performance.
Stakeholder Impact
- The sale of shares by the CFO could have a minor impact on shareholders due to the increased supply of shares in the market, but this is likely to be minimal given the context of tax obligations.
- Employees holding RSUs may be interested in the vesting schedule and potential tax implications.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | First vesting date of RSU award. |
| 10/01/2024 | Second vesting date of RSU award. |
| 01/01/2025 | RSUs vested and converted to common stock. |
| 01/03/2025 | Shares sold to cover tax obligations. |
| 04/01/2025 | Fourth vesting date of RSU award. |
| 07/01/2025 | Fifth vesting date of RSU award. |
| 10/01/2025 | Sixth vesting date of RSU award. |
| 01/01/2026 | Seventh vesting date of RSU award. |
| 04/01/2026 | Final vesting date of RSU award. |
| 01/06/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.